DKK1 and Miyoshi myopathy: The emergence of bone anabolic activity with anti-DKK1 antibody [119,120], lithium chloride [121], and activin A inhibitor [122,123], as well as with the enforced expression of Wnt3a within bone [124], has also been observed in MM animal models.